Read Complete Article/Study Here

July 5, 2017 – Rate of joint replacement in patients with RA declined after inclusion of biologics in treatment guidelines

MADRID — Among patients with rheumatoid arthritis, the incidence of knee and hip replacement declined after the introduction of biologics to national treatment guidelines, according to a recently published analysis.

“Our findings show a clear downward trend in these two operations in [rheumatoid arthritis] RA patients in Denmark since the additions of [biologic disease-modifying antirheumatic drugs] bDMARDs to treatment protocols,” Lene Dreyer, MD, from the Center for Rheumatology and Spine Diseases in Denmark, said. “Also, the overall pattern of our findings is in line with those recently reported from England and Wales.”